Cure Today6d
GI Bleeding Significantly Impacts GIST Treatment Outcomes
The prognosis of patients with gastrointestinal stromal tumors is significantly impacted by gastrointestinal bleeding.
BioTechniques5d
Recreating the tumor microenvironment with 3D bioprinting technology
Cancer models developed with 3D bioprinting technology allow for rapid evaluation of individual drug responses.
BPMC Q4 Earnings and Sales Miss Estimates, Shares Decline
Blueprint Medicines' fourth-quarter earnings and sales miss estimates. Shares of the company decline following the ...
Healio1d
FDA approves Gomekli for neurofibromatosis type 1 with plexiform neurofibromas
The FDA has approved an oral, small molecule MEK inhibitor for adult and pediatric patients 2 years of age and older with ...
Kura Oncology's SWOT analysis: stock poised for pivotal year ahead
Kura Oncology, Inc. (NASDAQ:KURA), a clinical-stage biopharmaceutical company focused on developing precision medicines for ...
Q1 Earnings Estimate for BPMC Issued By Leerink Partnrs
Leerink Partnrs issued their Q1 2025 EPS estimates for Blueprint Medicines in a research note issued on Thursday, February ...
JMP Securities Reaffirms “Market Outperform” Rating for Blueprint Medicines (NASDAQ:BPMC)
JMP Securities reiterated their market outperform rating on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in a ...
Scientific Research Publishing6d
Molecular Mechanisms of the CIRBP Family in Tumors: Current Status and Future Perspectives ()
CIRBP Family, Tumors, Molecular Mechanisms, RNA-Binding Proteins, Cellular Stress Share and Cite: Cai, Y. , Wang, T. and Zhan ...
asco.org3d
Use of ponatinib to inhibit kinase mutations associated with drug-resistant gastrointestinal stromal tumors (GIST).
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org6d
Regorafenib treatment for advanced, refractory gastrointestinal stromal tumor: A report of the U.K. Managed Access Program.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...